Bing‐Mae Chen
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Immunology top 10%
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction
Papers in
-
- Glycosylation and Glycoproteins Research 5
- Protein purification and stability 3
-
- Monoclonal and Polyclonal Antibodies Research 9
- Co-authors
- Steve R. Roffler (25 shared papers)Tian-Lu Cheng (3 shared papers)Tian‐Lu Cheng (5 shared papers)Ji‐Wang Chern (4 shared papers)Mi‐Hua Tao (1 shared paper)Pei‐Chun Wu (1 shared paper)André Lieber (1 shared paper)Lung‐Sen Kao (1 shared paper)
- Journals
- Journal of Controlled Release (4 papers)PLoS ONE (3 papers)ACS Nano (2 papers)International Journal of Cancer (2 papers)The Journal of Immunology (1 paper)
- Partner nations
- TaiwanUnited StatesIsrael
In The Last Decade
Bing‐Mae Chen
25 papers receiving 1.1k citations
Bing‐Mae Chen's Hit Papers
Peers
Comparison fields: 5 of 97
- Biomaterials 257
- Immunology 266
- Immunology and Allergy 62
- Pharmaceutical Science 66
- Radiology, Nuclear Medicine and Imaging 183
Countries citing papers authored by Bing‐Mae Chen
This map shows the geographic impact of Bing‐Mae Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing‐Mae Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing‐Mae Chen more than expected).
Fields of papers citing papers by Bing‐Mae Chen
This network shows the impact of papers produced by Bing‐Mae Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing‐Mae Chen. The network helps show where Bing‐Mae Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Bing‐Mae Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Polyethylene Glycol Immunogenicity: Theoretical, Clinical, and Practical Aspects of Anti-Polyethylene Glycol Antibodies Hit paper breakdown → | 2021 | 414 |
| 2 | 2010 | 172 | |
| 3 | Tumor-associated antigen L6 and the invasion of human lung cancer cells. | 2003 | 74 |
| 4 | 2023 | 61 | |
| 5 | 2000 | 59 | |
| 6 | 2023 | 58 | |
| 7 | 1997 | 46 | |
| 8 | 2021 | 33 | |
| 9 | 2021 | 31 | |
| 10 | 1997 | 27 | |
| 11 | 2019 | 24 | |
| 12 | 2023 | 22 | |
| 13 | 2021 | 20 | |
| 14 | 2009 | 17 | |
| 15 | Therapy of human cervical carcinoma with monoclonal antibody-Pseudomonas exotoxin conjugates. | 1991 | 15 |
| 16 | 2015 | 14 | |
| 17 | 2017 | 13 | |
| 18 | 2016 | 12 | |
| 19 | 2013 | 10 | |
| 20 | 2014 | 8 |
About Bing‐Mae Chen
Bing‐Mae Chen is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging, Immunology, Oncology and Hematology, having authored 25 papers that have together received 1.1k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (9 papers), Glycosylation and Glycoproteins Research (5 papers), Protein purification and stability (3 papers), Immunotherapy and Immune Responses (3 papers), Cell Adhesion Molecules Research (3 papers), Inhalation and Respiratory Drug Delivery (2 papers), Blood groups and transfusion (2 papers) and Nanoparticle-Based Drug Delivery (2 papers). The work is most often cited by research in Biomaterials (257 citations), Immunology (266 citations), Immunology and Allergy (62 citations), Pharmaceutical Science (66 citations) and Radiology, Nuclear Medicine and Imaging (183 citations). Bing‐Mae Chen has collaborated with scholars based in Taiwan, United States and Israel. Frequent co-authors include Steve R. Roffler, Tian-Lu Cheng, Tian‐Lu Cheng, Ji‐Wang Chern, Mi‐Hua Tao, Pei‐Chun Wu, André Lieber, Lung‐Sen Kao, Ming‐Fang Wu and Yi‐Chen Lin. Their work appears in journals such as Journal of Controlled Release, PLoS ONE, ACS Nano, International Journal of Cancer and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.